
Sudhakar Katakam
Examiner (ID: 15718)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1658, 1676, 1671, 1621 |
| Total Applications | 1810 |
| Issued Applications | 1243 |
| Pending Applications | 144 |
| Abandoned Applications | 465 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16985479
[patent_doc_number] => 11072635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Macrocyclic broad spectrum antibiotics
[patent_app_type] => utility
[patent_app_number] => 15/777509
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43299
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777509
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777509 | Macrocyclic broad spectrum antibiotics | Nov 20, 2016 | Issued |
Array
(
[id] => 16312341
[patent_doc_number] => 20200291079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => ENGINEERING STRUCTURALLY DEFINED NON-SACCHARIDE GLYCOSAMINOGLYCAN MIMETICS VIA A POLYPROLINE SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 15/775354
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775354
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775354 | ENGINEERING STRUCTURALLY DEFINED NON-SACCHARIDE GLYCOSAMINOGLYCAN MIMETICS VIA A POLYPROLINE SCAFFOLD | Nov 10, 2016 | Abandoned |
Array
(
[id] => 11471473
[patent_doc_number] => 20170058256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'CELL CULTURE MEDIUM COMPRISING SMALL PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/349791
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18067
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349791
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349791 | Cell culture medium comprising small peptides | Nov 10, 2016 | Issued |
Array
(
[id] => 11828672
[patent_doc_number] => 09725406
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-08-08
[patent_title] => 'Substituted hydroxystilbenes and their therapeutic applications'
[patent_app_type] => utility
[patent_app_number] => 15/338232
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5721
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338232 | Substituted hydroxystilbenes and their therapeutic applications | Oct 27, 2016 | Issued |
Array
(
[id] => 11442311
[patent_doc_number] => 20170043332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'Method for Preparation of a Ruthenium Indenylidene Complex'
[patent_app_type] => utility
[patent_app_number] => 15/335493
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5791
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335493
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335493 | Method for Preparation of a Ruthenium Indenylidene Complex | Oct 26, 2016 | Abandoned |
Array
(
[id] => 11669897
[patent_doc_number] => 20170158618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'TRANILAST COMPOSITIONS AND COCRYSTALS'
[patent_app_type] => utility
[patent_app_number] => 15/336154
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 12422
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/336154 | Tranilast compositions and cocrystals | Oct 26, 2016 | Issued |
Array
(
[id] => 11434837
[patent_doc_number] => 20170035858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'MYOBLAST DIFFERENTIATION PROMOTER'
[patent_app_type] => utility
[patent_app_number] => 15/299172
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3733
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299172
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299172 | Myoblast differentiation promoter | Oct 19, 2016 | Issued |
Array
(
[id] => 11421246
[patent_doc_number] => 20170029391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'CYCLOHEXENYL COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/293155
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6880
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/293155 | CYCLOHEXENYL COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS | Oct 12, 2016 | Abandoned |
Array
(
[id] => 11542736
[patent_doc_number] => 20170096561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'FLUORESCENT PROBE'
[patent_app_type] => utility
[patent_app_number] => 15/292858
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18630
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292858
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/292858 | Fluorescent probe | Oct 12, 2016 | Issued |
Array
(
[id] => 11828742
[patent_doc_number] => 09725475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Arsenoplatin anti-cancer agents'
[patent_app_type] => utility
[patent_app_number] => 15/291274
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20380
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291274
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/291274 | Arsenoplatin anti-cancer agents | Oct 11, 2016 | Issued |
Array
(
[id] => 11554234
[patent_doc_number] => 20170100481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'TRANSDERMAL PHARMACEUTICAL COMPOSITIONS WITH REDUCED SKIN IRRITATION'
[patent_app_type] => utility
[patent_app_number] => 15/287976
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6131
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287976 | TRANSDERMAL PHARMACEUTICAL COMPOSITIONS WITH REDUCED SKIN IRRITATION | Oct 6, 2016 | Abandoned |
Array
(
[id] => 13457877
[patent_doc_number] => 20180280481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/766546
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766546
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766546 | Pharmaceutical formulations for the oral delivery of peptide drugs | Oct 6, 2016 | Issued |
Array
(
[id] => 13489923
[patent_doc_number] => 20180296504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Novel Antioxidizing Intraocular Perfusion Solution
[patent_app_type] => utility
[patent_app_number] => 15/762726
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762726 | Antioxidizing intraocular perfusion solution | Sep 29, 2016 | Issued |
Array
(
[id] => 19025860
[patent_doc_number] => 11925197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Beta-caseins and gut microbiota
[patent_app_type] => utility
[patent_app_number] => 16/333939
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4956
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333939 | Beta-caseins and gut microbiota | Sep 29, 2016 | Issued |
Array
(
[id] => 11894000
[patent_doc_number] => 09763919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Detecting and treating growth hormone deficiency'
[patent_app_type] => utility
[patent_app_number] => 15/271542
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15271542
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/271542 | Detecting and treating growth hormone deficiency | Sep 20, 2016 | Issued |
Array
(
[id] => 11382843
[patent_doc_number] => 20170008900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'BICYCLIC COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/272114
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23815
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15272114
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/272114 | Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors | Sep 20, 2016 | Issued |
Array
(
[id] => 11521523
[patent_doc_number] => 09604908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Diether based biodegradable cationic lipids for siRNA delivery'
[patent_app_type] => utility
[patent_app_number] => 15/269197
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12936
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/269197 | Diether based biodegradable cationic lipids for siRNA delivery | Sep 18, 2016 | Issued |
Array
(
[id] => 13425161
[patent_doc_number] => 20180264123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => LONG-ACTING ADRENOMEDULLIN DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 15/760310
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760310 | Long-acting adrenomedullin derivative | Sep 15, 2016 | Issued |
Array
(
[id] => 16642099
[patent_doc_number] => 10919935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Antimicrobial peptide derived from myxinidin peptide and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/757793
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 12080
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757793 | Antimicrobial peptide derived from myxinidin peptide and uses thereof | Sep 11, 2016 | Issued |
Array
(
[id] => 13674993
[patent_doc_number] => 20160376230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => UREA GRANULATION PROCESS WITH SCRUBBING SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/260018
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260018 | Urea granulation process with scrubbing system | Sep 7, 2016 | Issued |